| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |